Literature DB >> 7676625

Functional characterisation of the genomic and antigenomic promoters of Sendai virus.

P Calain1, L Roux.   

Abstract

A natural Sendai virus internal deletion defective interfering (DI) RNA, previously shown to encode a truncated NP protein and previously cloned under the control of the T7 RNA polymerase promoter, was expressed from plasmid and shown to replicate in cell tissue culture when the viral proteins NP, P, and L were coexpressed from cloned genes. The efficient replication was dependent on the total length of the RNA to be a multiple of 6 nucleotides, showing that the "rule of six" applied for a DI RNA that has conserved the end sequences of the nondefective viral RNA. Compared to the copy-back H4 DI RNA, the replication efficiency of the internal deletion DI RNA was reproducibly 20-fold lower. Reciprocal exchanges between the minus-strand 3'-end primary sequences of the two DI RNAs showed that the replication efficiency of the derivatives obtained directly correlated with the origin and the extent of the primary sequence. Moreover, some of the derivatives exhibited a replication efficiency comparable to that of the copy-back DI RNA with, however, the ability to transcribe a functional mRNA similar to the internal deletion DI RNA. This indicated that the transcription ability of a viral RNA was not sufficient to explain a low replication efficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676625     DOI: 10.1006/viro.1995.1464

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally.

Authors:  Diane Vulliémoz; Laurent Roux
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymerase.

Authors:  Philippe Le Mercier; Dominique Garcin; Eduardo Garcia; Daniel Kolakofsky
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP).

Authors:  Jason P Roth; Joseph K-K Li; Dale L Barnard
Journal:  Curr Protoc Microbiol       Date:  2010-05

5.  Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.

Authors:  David R McGivern; Peter L Collins; Rachel Fearns
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals.

Authors:  Vanessa M Cowton; Rachel Fearns
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions.

Authors:  S Finke; K K Conzelmann
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Analysis of nucleotides 13-96 of the human parainfluenza virus type 3 antigenomic promoter reveals positive- and negative-acting replication elements.

Authors:  Jill R Gander; LeeAnne M Schwan; Michael A Hoffman
Journal:  Virology       Date:  2011-08-30       Impact factor: 3.616

9.  The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.

Authors:  C Tapparel; D Maurice; L Roux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins.

Authors:  C Tapparel; S Hausmann; T Pelet; J Curran; D Kolakofsky; L Roux
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.